Ulf Hannelius

President & CEO, Diamyd Medical

About this speaker

Born in 1975. PhD in Molecular Biology from Karolinska Institutet in Stockholm and Executive MBA from Stockholm School of Economics. Prior experience from business development in the biotech and medtech industries as well as from academic research in the fields of genetics and molecular biology. Chairman of Diamyd Biomanufacturing AB, Board member in MainlyAI AB. Joined Diamyd Medical in 2015, CEO since 2016.

Talks

Session Two: Current State of Clinical Trials in New-Onset T1D

17 June 2025, 05:00 PM
Matthias von Herrath Tadej Battelino Joshua A. Vieth, PhD Ulf Hannelius Carla Greenbaum Carmella Evans-Molina, MD, PhD Lauren Wood Heickman, MD Laura Knecht, MD Peter Gottlieb, MD